Laddar...
The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma A Review
IMPORTANCE: For more than a decade, sorafenib has been the only systemic treatment option for patients with advanced hepatocellular carcinoma (HCC). However, rapid progress over the past few years led to approval of other angiogenesis inhibitors and several immune checkpoint blockers (ICBs) that hav...
Sparad:
| I publikationen: | JAMA Oncol |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2021
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8265820/ https://ncbi.nlm.nih.gov/pubmed/33090190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2020.3381 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|